Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (Uniplant)
Author
dc.contributor.author
Barnhart, Kurt
Author
dc.contributor.author
Sir Petermann, Teresa
Author
dc.contributor.author
Devoto, Luigi
Author
dc.contributor.author
Robinovic, Jorge
Author
dc.contributor.author
Pommer, Ricardo
Author
dc.contributor.author
Coutinho, Elsimar
Admission date
dc.date.accessioned
2019-01-29T15:55:05Z
Available date
dc.date.available
2019-01-29T15:55:05Z
Publication date
dc.date.issued
1997
Cita de ítem
dc.identifier.citation
Fertility and Sterility, Volumen 67, Issue 2, 2018, Pages 250-255
Identifier
dc.identifier.issn
00150282
Identifier
dc.identifier.other
10.1016/S0015-0282(97)81906-1
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/162781
Abstract
dc.description.abstract
Objective: To evaluate a nomegestrol acetate subdermal contraceptive implant's (Uniplant; Thermex, Monaco) effect on the hypothalamus-pituitary- ovarian axis. Design: A prospective clinical trial. Setting: San Borja- Arriaran Clinical Hospital, University of Chile, School of Medicine. Patient(s): Normally cycling healthy women. Intervention(s): Insertion of Uniplant. Main Outcome Measure(s): Luteinizing hormone pulse and endocrine profiles were assessed before, 48 hours after insertion, and after prolonged use of the implant. Result(s): Anovulation was noted in 100% of users in the first month. Seventy percent of subjects demonstrated follicular development with the absence of ovulation and an endocrine profile similar to the follicular phase: (LH pulse/8 hours 6.85 ± 0.67, LH amplitude 3.54 ± 0.65 mIU/mL (conversion factor to SI unit, 1.00), and E2 193 ± 29.4 pg/mL (conversion factor to SI unit, 3.67), whereas 30% demonstrated no follicular activity with an endocrine profile similar t